Tuesday, October 25, 2016 | 9:00 AM - 5:00 PM
Speakers: Marcus Bantscheff (Cellzome/GSK), Benjamin F Cravatt (The Scripps Research Institute), Craig Crews (Yale University), Howard Hang (The Rockefeller University), Ruth Nussinov (National Cancer Institute), Brian Raymer (Pfizer), Bryan Roth (University of North Carolina), Eranthie Weerapana (Boston College)
Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.
Thursday, November 3, 2016 | 9:00 AM - 5:00 PM
Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Universite Catholique de Louvain, LDRI), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)
The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.
Wednesday, November 9, 2016 | 8:30 AM - 5:15 PM
Keynote Speaker: Lawrence D. Mayer (Jazz Pharmaceuticals)
Explore approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and compare biological and non-biological complex drug families.
Thursday, November 10, 2016 | 8:00 AM - 6:00 PM
Speakers: Iannis Aifantis (NYU School of Medicine), Emily Bernstein (Icahn School of Medicine at Mount Sinai), Ryan Kruger (GlaxoSmithKline), Ross L. Levine (Memorial Sloan Kettering Cancer Center), Sheng Li (Jackson Laboratory for Genome Medicine), Christopher E. Mason (Weill Cornell Medicine), Kornelia Polyak (Dana Farber Cancer Institute, Harvard Medical School), Tim Somervaille (The University of Manchester), and Jorge DiMartino (Celgene)
This conference will explore novel target and validation strategies, translational approaches to assess predictive and response biomarkers, resistance mechanisms, and combination strategies for targeting epigenetic susceptibilities in cancer.
Tuesday, November 15, 2016 | 9:00 AM - 5:00 PM
Speakers: Thaddeus Stappenbeck (Washington University School of Medicine), Declan F. McCole (University of California Riverside), Jerrold R. Turner (Brigham and Women's Hospital), Linda G. Griffith (MIT), Tim Denning (Georgia State University), and Alan Hanash (Memorial Sloan Kettering Cancer Center)
This symposium will evaluate emerging research investigating the benefits of achieving mucosal healing in the treatment of intestinal disorders.
Friday, October 7, 2016 | 9:00 AM - 5:00 PM
Mental illness causes debilitating consequences on quality of life for individuals, families, and society. This symposium explores avenues for translating these discoveries about the neurobiology of a spectrum of mental illnesses into new treatments.
Monday, October 3, 2016 | 1:30 PM - 4:30 PM
Speakers: Marcin Imielinski (Weill Cornell Medicine), Christopher Lima (Memorial Sloan Kettering Cancer Center), Barry Sleckman (Weill Cornell Medicine), Alexandra Zidovska (New York University)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Thursday, September 22, 2016 | 8:00 AM - 2:15 PM
Featuring: Yoshinori Ohsumi (Tokyo Institute of Technology)
The 2016 Dr. Paul Janssen Award Symposium will honor Dr. Yoshinori Ohsumi for his groundbreaking research demonstrating that autophagy is a crucial process in maintaining cellular homeostasis as well as establishing its role in human health.
September 21 - 23, 2016
Featuring: Peder S. Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)
Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.
Featured Speaker: Peter Godfrey-Faussett (UNAIDS)
Participants gathered at the New York Academy of Sciences to discuss one of the next frontiers in the HIV field: how NCDs and HIV interact, how they should be treated, and how policy needs to adapt to facilitate effective treatment for people living with NCDs.
Edited by Juan Pablo Peña-Rosas
(World Health Organization), Maria Nieves Garcia-Casal
(Venezuelan Institute for Scientific Research), and Luz María De-Regil
This Annals issue is the second of two issues stemming from a WHO consultation on the fortification of condiments and seasonings as a new approach to mitigate micronutrient deficiencies.
Free online access provided by the World Health Organization
Edited by Jeffrey D. Laskin
(Rutgers University School of Public Health)
Discussions of various countermeasures to chemical threats.
Keynote Speakers: John Bienenstock (McMaster University, Canada) and Jeffrey Gordon (Washington University in St. Louis)
This eBriefing discusses the links between gut microbiota, diet, and health. It covers topics including the microbiome in development; microbiome interactions outside the gut; and the therapeutic potential of targeting the microbiome.